Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3 [PDF]
Annet Bouma-de Krijger +4 more
openalex +1 more source
Parathyroidectomy in the treatment of uremic tumoral calcinosis: a 9-year case report and meta-analysis. [PDF]
Huang H +9 more
europepmc +1 more source
Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients. [PDF]
Zeng Q, Zhong Y, Yu X.
europepmc +1 more source
Sevelamer and pharmacokinetics of cyclosporin A after kidney transplantation [PDF]
Jadoul, Michel +3 more
core
Mineral bone disorders (MBD) in patients on peritoneal dialysis [PDF]
HANAFUSA Norio +2 more
core +2 more sources
Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management. [PDF]
Raju S, Saxena R.
europepmc +1 more source
Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis. [PDF]
Molina P +12 more
europepmc +1 more source
Drug interaction between sevelamer and cyclosporin [V. Varia Letter and Reply] [PDF]
Guillen-Anaya, Miguel-Angel +4 more
core

